AC IMMUNE SA Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019
AC IMMUNE SA (ACIU) had Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 of 4.5 CHF/shares as of 2024-12-31, per its 20-F filed 2025-03-13.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 · last filed 2025-03-13
- 2020-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 5.90 CHF.
- 2019-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 5.93 CHF.
- 2018-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 4.25 CHF.
- 2017-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 2.09 CHF.
CHF
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 |
|---|---|
| 2020-12-31 | 5.90 CHF 20-F · filed 2021-03-23 |
| 2019-12-31 | 5.93 CHF 20-F · filed 2021-03-23 |
| 2018-12-31 | 4.25 CHF 20-F · filed 2021-03-23 |
| 2017-12-31 | 2.09 CHF 20-F · filed 2021-03-23 |
| 2016-12-31 | 0.15 CHF 20-F · filed 2020-03-30 |
CHF/shares
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 |
|---|---|
| 2024-12-31 | 4.50 CHF/shares 20-F · filed 2025-03-13 |
| 2023-12-31 | 4.11 CHF/shares 20-F · filed 2025-03-13 |
| 2022-12-31 | 5.65 CHF/shares 20-F · filed 2025-03-13 |
| 2021-12-31 | 6.21 CHF/shares 20-F · filed 2025-03-13 |
| 2020-12-31 | 5.90 CHF/shares 20-F · filed 2024-03-14 |
| 2019-12-31 | 5.93 CHF/shares 20-F · filed 2023-03-16 |
| 2018-12-31 | 4.25 CHF/shares 20-F · filed 2022-03-22 |
| 2017-12-31 | 2.09 CHF/shares 20-F · filed 2021-03-23 |
| 2016-12-31 | 0.15 CHF/shares 20-F · filed 2020-03-30 |